Insurance carriers and drug makers are often demonized as unjust profiteers of the US healthcare system. In practice, 20 out of 23 Obamacare Co-ops have failed. This is due to a variety of factors, but certainly provides evidence that the free market operates somewhat efficiently. Recently, California SB SB852 provides a path to get the State of California into the generic drug manufacturing business. It will be interesting to see if the state is successful in taking over the means of production for generic drugs.